Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis.

Laboratory of Experimental Infection, Infectious Diseases Service and Microbiology Service, Ciutat Sanitària i Universitaria de Bellvitge, C.Feixa Larga s/n, 08907 L'Hospitalet, Barcelona, Spain.
Journal of Antimicrobial Chemotherapy (Impact Factor: 5.44). 04/2002; 49(3):507-13.
Source: PubMed

ABSTRACT The object of the study was to assess the efficacy of rifampicin and the combination of rifampicin plus vancomycin in a rabbit model of experimental penicillin-resistant pneumococcal meningitis. We also studied the effect of concomitant dexamethasone on the CSF antibiotic levels and inflammatory parameters. The rabbit model of pneumococcal meningitis was used. Groups of eight rabbits were inoculated with 106 cfu/mL of a cephalosporin-resistant pneumococcal strain (MIC of cefotaxime/ceftriaxone 2 mg/L). Eighteen hours later they were treated with rifampicin 15 mg/kg/day, vancomycin 30 mg/kg/day or both plus minus dexamethasone (0.25 mg/kg/day) for 48 h. Serial CSF samples were withdrawn to carry out bacterial counts, antibiotic concentration and inflammatory parameters. Rifampicin and vancomycin promoted a reduction of >3 log cfu/mL at 6 and 24 h, and cfu were below the level of detection at 48 h. Combination therapy with vancomycin plus rifampicin was not synergic but it had similar efficacy to either antibiotic alone and it was able to reduce bacterial concentration below the level of detection at 48 h. Concomitant use of dexamethasone decreased vancomycin levels when it was used alone (P< 0.05), but not when it was used in combination with rifampicin. Rifampicin alone at 15 mg/kg/day produced a rapid bactericidal effect in this model of penicillin-resistant pneumococcal meningitis. The combination of vancomycin and rifampicin, although not synergic, proved to be equally effective. Using this combination in the clinical setting may allow rifampicin administration without emergence of resistance, and possibly concomitant dexamethasone administration without significant interference with CSF vancomycin levels.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Recreation specialization group differences in support for multi-attribute management restrictions using a stated preference choice approach were tested. A fractional factorial design produced 80 choice sets of paired trip comparisons. A three dimensional recreation specialization model (i.e., behavior, skill and knowledge, and commitment) was used to segment groups. As expected, advanced anglers were less interested in relaxing the more restrictive harvest restrictions currently in place that produce the fishing quality they enjoyed. Casual anglers showed a strong preference for catching more fish by relaxing current harvest restrictions. Each specialization group showed a notably different pattern of preference.
    Leisure Sciences 09/2006; 28(4):369-384. · 1.07 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Central nervous system (CNS) infections are frequently encountered in the intensive care unit setting and are a significant source of morbidity and mortality. The constantly changing trends in microbial resistance, as well as the pharmacokinetic difficulties in providing effective concentrations of antimicrobials at the site of infection represent a unique challenge to clinicians. Achievement of a successful outcome in patientswith CNS infections is reliant on eradication of the offending pathogen and management of any neurologic complications. This requires an anatomic and physiologic understanding of the different types of CNS infection, diagnostic strategies, associated complications, causative organisms, and the principles that govern drug distribution into the CNS. This article serves as a review of the epidemiology, pathophysiology, diagnosis, and treatment options for a variety of CNS infections, with a focus on those commonly encountered in an intensive care setting.
    Journal of Pharmacy Practice 02/2005; 18(1):25-41.
  • [Show abstract] [Hide abstract]
    ABSTRACT: To determine the efficacy of daptomycin for the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis using in vitro and in vivo methods.
    Journal of Antimicrobial Chemotherapy 06/2014; · 5.44 Impact Factor